iShares Biotechnology ETF $IBB Shares Sold by Walleye Capital LLC

Walleye Capital LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 55.6% during the first quarter, Holdings Channel reports. The institutional investor owned 3,670 shares of the financial services provider’s stock after selling 4,588 shares during the period. Walleye Capital LLC’s holdings in iShares Biotechnology ETF were worth $469,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Kestra Advisory Services LLC increased its position in shares of iShares Biotechnology ETF by 1.9% during the first quarter. Kestra Advisory Services LLC now owns 38,177 shares of the financial services provider’s stock worth $4,883,000 after purchasing an additional 703 shares in the last quarter. RPG Investment Advisory LLC acquired a new stake in shares of iShares Biotechnology ETF during the first quarter worth about $257,000. CW Advisors LLC increased its position in shares of iShares Biotechnology ETF by 233.5% during the first quarter. CW Advisors LLC now owns 8,058 shares of the financial services provider’s stock worth $1,033,000 after purchasing an additional 5,642 shares in the last quarter. Tradition Wealth Management LLC increased its position in shares of iShares Biotechnology ETF by 3.5% during the first quarter. Tradition Wealth Management LLC now owns 57,817 shares of the financial services provider’s stock worth $7,395,000 after purchasing an additional 1,967 shares in the last quarter. Finally, Erste Asset Management GmbH increased its position in shares of iShares Biotechnology ETF by 61.5% during the first quarter. Erste Asset Management GmbH now owns 63,000 shares of the financial services provider’s stock worth $8,058,000 after purchasing an additional 24,000 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.6%

IBB opened at $140.41 on Wednesday. The business’s 50-day simple moving average is $133.46 and its 200-day simple moving average is $128.89. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $150.57.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.